Filing Flows › Insight Molecular Diagnostics (IMDX) › How it makes money
How Insight Molecular Diagnostics (IMDX) makes money
Insight Molecular Diagnostics (IMDX) made $239K of revenue in the second quarter 2026 (Q2 2026), -54% from a year earlier. Laboratory Services brought in $218K (91%); Kitted Products brought in $21K (9%).
Drawing the Sankey…
Revenue by segment, Q2 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Laboratory Services | $218K | 91.2% | — | -56% |
| Kitted Products | $21K | 8.8% | — | -12% |
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $239K | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $239K | -54% |
| Q1 2026 | $32K | -98% |
| Q4 2025 | $1.1M | -23% |
| Q3 2025 | $260K | +126% |
| Q2 2025 | $518K | +398% |
| Q1 2025 | $2.1M | 12× |
| Q4 2024 | $1.5M | +373% |
From Insight Molecular Diagnostics' 10-Q filed Aug 10, 2026 (on EDGAR).
Questions
How does Insight Molecular Diagnostics make money?
Insight Molecular Diagnostics (IMDX) made $239K of revenue in the second quarter 2026 (Q2 2026), -54% from a year earlier. Laboratory Services brought in $218K (91%); Kitted Products brought in $21K (9%).
What is Insight Molecular Diagnostics' biggest business?
Laboratory Services: $218K in the second quarter 2026, 91% of revenue, -56% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.